4Coloman R. Clinical aspects of metastasis bone disease. In:Coloman R, Rubens RD, eds , metastasis bone disease[J]. Camforth : The Parthenon Publishing Group Lid, 1992:11.
5Major P,Lortholary A,Hon J,et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy:a pooled analysis of two randomized ,controlled clinical trials[J]. J Clin Oncol, 2001, 19:558-567.
6Eydokiou A, Labrinidis A. Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis[J]. Bone, 2003,33 (2) : 216-228.
7Neville-Webbe H, Coleman RE. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia[J]. Palliat Med, 2003,17(6):539-553.
8Richard P.Introduction:The scope of breakthrough pain in clinical practice[J].Pain Medicine,2007,8(11):1-2.
9张天泽 徐光炜.肿瘤学[M].天津：天津科学技术出版社,1996.1209.
10Theriault RL, Lipton A, Hortobagyi CN, et al. Pamidronate reduces skeletal, morbidiy in women with advanced breast cancer and cytic bone lesion:a randomized, placebo-contrdled trial protocol 18 Areia Breast Cancer Study Group[J]. J Clin Oncol, 1999,17(3) :846 - 854.
